See All Slides - tctmd.com

Slides

Presentation TCT 2013

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Presenter: Bent Raungaard

October 29, 2013

Presentation

Efficient Evaluation for TAVR: What Do We Really Need?

Presenter: John Webb

October 29, 2013

Presentation TCT 2013

Case 2: Chronic Total Occulsion (Piedmont Heart Institute, Atlanta, GA)

Presenter: Julie Logan

October 29, 2013

Presentation

Is There Really a Problem? Revascularization of Calcified Coronary Lesions

Presenter: Philippe Généreux

October 29, 2013

Presentation TCT 2013

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Presenter: Lian R. Gao

October 29, 2013

Presentation TCT 2013

Repair vs. Replacement for Functional MR

Presenter: Robert Guyton

October 29, 2013

Presentation TCT 2013

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2013

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Presenter: Ulrich Jorde

October 29, 2013

Presentation TCT 2013

Case #1: Management of Residual Thrombus After Intracoronary Administration of Abciximab and Manual Thromboaspiration in STEMI.

Presenter: Alejandro Fernandez

October 29, 2013

Presentation TCT 2013

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Loes Hoebers

October 29, 2013

Advertisement

Slides

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Efficient Evaluation for TAVR: What Do We Really Need?

Case 2: Chronic Total Occulsion (Piedmont Heart Institute, Atlanta, GA)

Is There Really a Problem? Revascularization of Calcified Coronary Lesions

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Repair vs. Replacement for Functional MR

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Case #1: Management of Residual Thrombus After Intracoronary Administration of Abciximab and Manual Thromboaspiration in STEMI.

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content